chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient had facial and extremity rigidity, dilated pupils, agonal breaths, unable to palpate peripheral or corotated pulse, unresponsive to voice or painful stimuli. Medical staff lowered him to the ground, activated the Emergency Response System, checked for pulses, unable to visualize chest rise, initiated compressions and rescue breaths until pulse returned and patient was arousable and began spontaneously breathing. Patient independently checked into Hospital.
MILD PAIN IN THE SITE OF INJECTION; This spontaneous report received from a patient concerned a 35 year old of unspecified sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A expiry: UNKNOWN) dose was not reported, administered on 26-MAY-2021 for prophylactic vaccination. No concomitant medications were reported.  On 26-MAY-2021, the subject experienced mild pain in the site of injection. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of mild pain in the site of injection was not reported. This report was non-serious. This case, from the same reporter is linked to 20210556420, 20210556156 and 20210556038.
lost a friend of my son 14 years; This is a spontaneous report from a non-contactable consumer reporting same event under the same suspect product for 12 patients. This is one of 12 reports. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified routed of administration on unspecified date as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The reporter had lost a friend of the reporter's son 14 years (seems the reporter's son's age who is not the patient). The cause of death was unknown. It was unknown if autopsy was done. The outcome of the event was fatal.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101100059 Same reporter/event/drug, different patient; Reported Cause(s) of Death: lost a friend of my son 14 years
within 5 minutes of receiving injection felt it move through body and felt flushed,  an EMT took my bp = 165/107 and hr =117, felt super hot in gland areas, tingling in left jaw and tongue, flash headaches, light sensitivity, muffled hearing, itching skin, skin  crawling (tingling) all over.  Was given total of 75mg Benadryl along with  40mg Pepcid  Remained at the clinic for almost 2 hours,  symptoms persisted from day of injection Thursday March 25 - Monday March 29
This is in follow-up to report (s) previously submitted on 5/14/2007. Information has been received from a Registered Nurse (R.N.) concerning a 12 year old female patient who on 08-MAR-2007 was vaccinated with a second dose of Gardasil. Patient had a rash before getting the vaccination. On 08-MAR-2007 the patient's rash (on her chest and neck) became worse and she was shaking, had fever and sweating. Unspecified medical attention was sought. The patient recovered. Additional information has been requested. Initial and follow up information has been received from a Registered Nurse (R.N.) concerning a 20 year old (previously mentioned as 12 year old) female student with asthma and rash, hives to amoxicillin(+) clavulante potassium who on 08-MAR-2007 was vaccinated IM in left deltoid with a second dose of GARDASIL. Concomitant therapy included TRINESSA., montelukast sodium (MSD) and ZYRTEC. Patient had a rash before getting the vaccination. On 08-MAR-2077 the patient's rash ( on her chest and neck) became worse and she was shaking, had fever and sweating. Unspecified medical attention was sought. In follow up it was reported that on 09-MAR-2007 patient woke up at 01:00AM shaking shivering for 1 1/4 hour. At 4:30AM she broke out sweating with fever. On 11-MAR-2007 patient's mother reported that she recovered. Additional information is not expected.
he was so unstable/ almost fell; dizzy; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 72-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in arm left, administration date 21Apr2021 14:00 (Lot number: EW0169) at the age of 72 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "high blood pressure" (unspecified if ongoing); "cholesterol" (unspecified if ongoing); "sugar" (unspecified if ongoing). Concomitant medications included: METFORMIN taken for blood glucose abnormal (ongoing); SIMVASTATIN taken for lipid metabolism disorder (ongoing); HYDROCHLOROTHIAZIDE taken for hypertension (ongoing). The following information was reported: DIZZINESS (non-serious) with onset 21Apr2021, outcome "not recovered", described as "dizzy"; BALANCE DISORDER (non-serious) with onset 23Apr2021, outcome "not recovered", described as "he was so unstable/ almost fell". Therapeutic measures were not taken as a result of dizziness, balance disorder.  Additional information: When the patient went to bed on Wednesday (21Apr2021) night, he felt kind of dizzy. When he got up on Thursday morning (22Apr2021) he was really dizzy. It got better during the day. At night, he got dizzy again and on 23Apr2021 (morning) he was so dizzy that he almost fell. It seemed to be worse when he gets up out of bed. He has had to start using a cane because he was so unstable.  No follow-up attempts are possible. No further information is expected.
A couple moments after receiving my 1st covid vaccine I began experiencing dizziness, numbness in my face, couldn't feel my left leg for 30 minutes, went into convulsions for 20 minutes. They kept me for over an hour. Since then I have had chest pains almost all day each day, I have been dizzy, nauseous and back and forth between freezing and sweating.
pt recv vax & became pregnant;21FEB96 amniocentesis was nl;21MAR96 sonogram revealed a female fetus w/poss tetralogy of fallot;11JUL96 pt delivered live born female w/variant of tetralogy of fallot;pt was otherwise nl;
Heart palpitations; Tightness in chest; Shortness of breath; Fever; Chills; Headache; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0169) via an unspecified route of administration in the left arm on 15Apr2021 at 13:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and had known allergies to wheat and gluten. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamin d (MANUFACTURER UNKNOWN), vitamin B (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C), levoglutamide (L GLUTAMINE) and iron (MANUFACTURER UNKNOWN) all from an unknown date for unknown indication and unknown if ongoing. On 16Apr2021, the first two days, the patient experienced fever, chills, headache and nausea, felt fine but had these symptoms again. On 21Apr2021 at 03:00 (about 6 days after vaccination), the patient woke up with heart palpitations, tightness in chest and shortness of breath. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, headache, nausea, heart palpitations, tightness in chest and shortness of breath was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
I have many allergies and adverse events from prior vaccines, so I took a Benadryl before the injection. I was very pleased nothing detrimental happened at the time. My head and neck were a little itchy but went away, some dizzyness but went away, all after about an hour. The arm didn't blow up like usual.  That night, I started to experience the usual vaccine side effects i.e. headache, feverish, sweating, joint aches. All this I expected starting around 8:45 -9pm.   At about 10 - 10:30 pm, I began to have abdomen pain/pelvic pain... I started feeling like I was getting period cramps and lower intestinal discomfort. I just had my period though, so it didn't make sense (about 7 -10 days ago). I am also on the pill so I know for a fact I just had it and started a new pack. I was very confused and thought it was odd...can't be, maybe it would go away.   I woke up about 3am with intense uterus/period cramps which kept me up, in and out of sleep. About 5am I felt like I had my period (fluid down there), went to the bathroom and indeed, I was bleeding... a lot. The cramps continued, the bleeding continued and now 6 days later it is finally going away. I never get head aches and my head has continued to hurt on and off also.
Sore arm; Tiredness; This is a spontaneous report from a contactable consumer. An elderly female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) at a single dose, with route of administration and therapy date unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on an unspecified date for COVID-19 immunization. The patient was not pregnant at the time of vaccination. In Jan2021, the patient had sore arm and tiredness. The patient did not receive any treatment for the reported events. The outcome of the events, sore arm and tiredness, was recovered in Jan2021. The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested post-vaccination.  Information about lot/batch has been requested.
Fever; Fatigue; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), FATIGUE (Fatigue), HEADACHE (Headache) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), FATIGUE (Fatigue), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, PYREXIA (Fever), FATIGUE (Fatigue), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Body temperature: 100.3 f (High) 100.3 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator Aleve used as a Treatment Medication.
Patient described injection site area as hard, raised, swelling 1/2 inch. Area was approximately 6 inches by 4 inches. Patient experienced painful, burning sensation. Patient did go to Urgent Care.
left arm has been killing him; range of motion is limited; rotator cuff injury; nerve damage; arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (left arm has been killing him), MOBILITY DECREASED (range of motion is limited), ROTATOR CUFF SYNDROME (rotator cuff injury), NERVE INJURY (nerve damage) and VACCINATION SITE PAIN (arm is sore) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 037A21B) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (left arm has been killing him), MOBILITY DECREASED (range of motion is limited), ROTATOR CUFF SYNDROME (rotator cuff injury), NERVE INJURY (nerve damage) and VACCINATION SITE PAIN (arm is sore). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Pain, at a dose of 1 dosage form. At the time of the report, PAIN (left arm has been killing him), MOBILITY DECREASED (range of motion is limited), ROTATOR CUFF SYNDROME (rotator cuff injury), NERVE INJURY (nerve damage) and VACCINATION SITE PAIN (arm is sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273(Moderna COVID-19 Vaccine) was not applicable  No concomitant medications were reported
Extreme diarrhea and vomiting. Some relief with immodium, but lasted over 48hrs
sore arm; body ache; Bad headache; vomiting; chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm), MYALGIA (body ache), HEADACHE (Bad headache), VOMITING (vomiting) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm), MYALGIA (body ache), HEADACHE (Bad headache), VOMITING (vomiting) and CHILLS (chills). At the time of the report, VACCINATION SITE PAIN (sore arm), MYALGIA (body ache), HEADACHE (Bad headache), VOMITING (vomiting) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication history was not provided. Treatment for these events were not provided.     Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.
COVID-19; STOMACH VIRUS; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) and GASTROENTERITIS VIRAL (STOMACH VIRUS) in an adult female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced COVID-19 (COVID-19) and GASTROENTERITIS VIRAL (STOMACH VIRUS). At the time of the report, COVID-19 (COVID-19) and GASTROENTERITIS VIRAL (STOMACH VIRUS) had resolved.            Concomitant medication was not reported. Treatment details were not reported.  It was unknown if patient was enrolled in a COVID-19 vaccine trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
pain in inner area of arm and it runs to my elbow, cant extend my arm out because there is alot of pain.
Patient had her upper arm swell with warmth to the touch and she had soreness for almost a month.  She said it went away on its own but did not report it until her second dose.
He received the whole primary series and one boosters with Pfizer's COVID-19 Vaccine and one of the boosters was from Moderna. However, he tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (He received the whole primary series and one boosters with Pfizer's COVID-19 Vaccine and one of the boosters was from Moderna. However, he tested positive for COVID-19) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.    Co-suspect products included non-company products TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication and NIRMATRELVIR, RITONAVIR (PAXLOVID) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form, dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form On an unknown date, received dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form and dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. and NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On an unknown date, the patient experienced COVID-19 (He received the whole primary series and one boosters with Pfizer's COVID-19 Vaccine and one of the boosters was from Moderna. However, he tested positive for COVID-19). At the time of the report, COVID-19 (He received the whole primary series and one boosters with Pfizer's COVID-19 Vaccine and one of the boosters was from Moderna. However, he tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2023, SARS-CoV-2 test: (Positive) Tested positive again. On an unknown date, SARS-CoV-2 test: Positive.         Concomitant product use was not provided by the reporter.    The patient was fully vaccinated, received the whole primary series and one boosters with Pfizer's COVID- 19 vaccine and one of the boosters was from Moderna. However, patient tested positive for COVID-19. At the time of the report, patient had to take Paxlovid whose last dose was the Sunday prior to the report and on the day of this report patient tested positive again for COVID-19.   Reporter did not allow further contact
ALOC, passed out 30 minutes after vaccine - syncope. BP 146/77 (pulse 59), O2 sat 98%.
9/17/2021 pt arrived to the Medical Center via ambulance with c/o SOB, cough, O2 sats 80% on RA; placed on O2 supplementation; found to have COVID pneumonia; positive COVID test; pt states had a positive COVID test on 8/4/21 and the sx resolved until now; pt's condition worsened requiring a tracheostomy; pt became stable and was transferred on 10/5/21 to another hospital for further care; pt developed fever, was put on ABX; required an increase in ventilator support; family decided to transition pt to comfort care and he passed away in the hospital
Headache, nausea, fever, chills, body ache, swollen/painful lymph node, sore arm, brain fog, fatigue
before bedtime the day I received my booster, I felt very dizzy as I sat on the toilet to urinate. I then felt nauseous, tried to to stand. Next thing I knew, I woke up face up on the bathroom floor. I sat up and blood gushed from my nose. I had syncope, hit my nose in the fall and fractured my anterior nasal bone.
patient got shingrix in left arm 1/2/2020 and rash showed up on right arm on 1/10/2020, patient went to doctor who diagnosed shingles
About 7 hours after the injection, patient experienced hives and itching. (side of back and under arm pits). Patient was given I.V. Prednisolone and BENADRYL in ER. All symptoms have subsided within 12 hours.
nerve damage to his arm; This spontaneous case was reported by a consumer and describes the occurrence of NERVE INJURY (nerve damage to his arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NERVE INJURY (nerve damage to his arm) (seriousness criterion hospitalization). The patient was treated with Physical therapy (Physical therapy) for Nerve injury. At the time of the report, NERVE INJURY (nerve damage to his arm) outcome was unknown.            No concomitant and treatment medications was provided by the reporter. Within a week after vaccination, the patient experienced nerve damage to his arm. He was in hospital for several days and he stated that he was going to physical therapy.  Company comment: This case concerns a male patient of an unknown age with no medical history provided, who experienced serious unexpected event of Nerve injury (reported as nerve damage to his arm) after the administration of the mRNA-1273 vaccine (as booster dose). The date of vaccination and the start date of the event were not provided, however, as per source document, it was stated that the event occurred within a week after vaccine administration. The patient was initially hospitalized for several days due to reported event and at the time of this report, the patent was going to physical therapy. No additional details regarding the clinical course of the event were disclosed. The rechallenge is not applicable as the event occurred following booster vaccination. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This case concerns a male patient of an unknown age with no medical history provided, who experienced serious unexpected event of Nerve injury (reported as nerve damage to his arm) after the administration of the mRNA-1273 vaccine (as booster dose). The date of vaccination and the start date of the event were not provided, however, as per source document, it was stated that the event occurred within a week after vaccine administration. The patient was initially hospitalized for several days due to reported event and at the time of this report, the patent was going to physical therapy. No additional details regarding the clinical course of the event were disclosed. The rechallenge is not applicable as the event occurred following booster vaccination. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.
Edema, erythema and induration @ site of injection, size 4.5 X 4.5 -left arm
Itchy, red, swollen, trouble breathing and shallowing, pain where shot was given, muscle pain, feeling tired, headache, shivering, upset stomach, vomiting, belly pain, and tingling of the lips.
Aches/pain within 6 to 8 hours; fever/chills next day.
approx 2wk p/vax pt devel chicken pox lesions, approx 10-12 on legs;no other signs or sx;